Needham & Company
-
Needham & Company Upgrades Spectranetics (SPNC) to Strong Buy
-
Needham & Company Cuts Price Target on Spectranetics (SPNC) to $24 Following 2Q15
-
Needham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal
-
Spectranetics (SPNC) Target, Estimates Cut at Needham & Company; Stumble Creates Buying Chance
-
Needham & Company Starts Spectranetics (SPNC) at Buy

